A New Oncology Era

Dr Terese Johansson, Regulatory Consultant, NDA Group has written a new article on tissue-agnostic drug development: A New Oncology Era 

Read about how recent developments in tumourigenesis genomics have paved the way for a molecular marker defining a disease that spans multiple histology-based tumours in a tissue-agnostic manner, in an article written by Terese Johansson, published in European Biopharmaceutical Review October 2018 pages 32-37.

To learn more please click on the brochure below and flick to pages 32-37.